In the current study, the decreased sclerostin expression in the non-transplanted CKD patients as compared to controls may either reflect a difference in osteocyte biology between children and adults or reflect the fact that PTH values, which are known to suppress sclerostin, were already mildly increased in this cohort. The gene discussed is SOST; the disease is chronic kidney disease.